There were fears for patients with the lung disease as Covid-19 emerged but new treatments have shown remarkable benefits
It threatened to be a calamitous year for those affected by Britain’s most widespread inherited illness, cystic fibrosis. The disease attacks patients’ lungs, leaving them dangerously susceptible to airborne infections. The appearance of Covid-19 – which can cause deadly lung disease and pneumonia in healthy individuals – triggered serious alarm among doctors, carers and patients.
“We were really worried that this previously unknown virus could be particularly bad news for people with cystic fibrosis,” said Keith Brownlee, a director at the Cystic Fibrosis Trust. “We thought this could be very dangerous.”
